Obalon Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
STANKOVICH THOMAS officer: Chief Financial Officer
 Common Stock, $0.001 par value per share 48,366 $2.89 $139,778
Sale
GLADNEY DAN W director
 Common Stock, $0.001 par value per share 200,000 $2.99 $598,000
Sale
BANDY BARTON P. director, officer: President an..
 Common Stock, $0.001 par value per share 294,494 $2.89 $851,088
Purchase
STANKOVICH THOMAS
Common Stock, $0.001 par value per share 15,000 $3.43 $51,435
Purchase
STANKOVICH THOMAS
Common Stock, $0.001 par value per share 15,000 $3.22 $48,285
Sale
ARMISTICE CAPITAL, LLC
Common Stock 685,583 $5.48 $3,756,995
Sale
ARMISTICE CAPITAL, LLC
Common Stock 1,106,210 $6.67 $7,372,890
Sale
ARMISTICE CAPITAL, LLC
Common Stock 511,676 $7.65 $3,915,856
Sale
ARMISTICE CAPITAL, LLC
Common Stock 511,676 $7.65 $3,915,856
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 65,000 N/A N/A
Purchase
BRISTER MARK officer: Chief Technology Officer
 Warrants (Right to Buy) 3,750 N/A N/A
Purchase
BRISTER MARK officer: Chief Technology Officer
 Common Stock 5,000 N/A N/A
Purchase
MACDONALD ROBERT J officer: Chief Retail Officer
 Warrants (Right to Buy) 3,750 N/A N/A
Purchase
MACDONALD ROBERT J officer: Chief Retail Officer
 Common Stock 5,000 N/A N/A
Purchase
HUSSAINY NOOSHIN officer: Chief Financial Officer
 Warrants (Right to Buy) 3,750 N/A N/A
Purchase
HUSSAINY NOOSHIN officer: Chief Financial Officer
 Common Stock 5,000 N/A N/A
Purchase
VANDENBERG AMY officer: Chief Clinical & Reg O..
 Warrants (Right to Buy) 1,875 N/A N/A
Purchase
VANDENBERG AMY officer: Chief Clinical & Reg O..
 Common Stock 2,500 N/A N/A
Purchase
RASDAL ANDREW P director, officer: President, C..
 Warrants (Right to Buy) 9,375 N/A N/A
Purchase
RASDAL ANDREW P director, officer: President, C..
 Common Stock 12,500 N/A N/A
Purchase
HOWE LESLEY H director
 Warrants (Right to Buy) 4,687 N/A N/A
Purchase
HOWE LESLEY H director
 Common Stock 6,250 N/A N/A
Purchase
KAMDAR KIM P. director
 Warrants to Purchase Common Stock 9,375 N/A N/A
Purchase
KAMDAR KIM P. director
 Common Stock 12,500 N/A N/A
Purchase
STEVENSON SHARON director
 Warrants (Right to Buy) 5,625 N/A N/A
Purchase
STEVENSON SHARON director
 Common Stock 7,500 N/A N/A
Purchase
PLOVANIC WILLIAM J. director
 Warrants (Right to Buy) 9,375 N/A N/A
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 12,500 N/A N/A
Purchase
DOMAIN PARTERS VII L P 10 percent owner
 Warrants to Purchase Common Stock 187,500 N/A N/A
Purchase
DOMAIN PARTERS VII L P 10 percent owner
 Common Stock 250,000 N/A N/A
Purchase
INTERWEST PARTNERS X LP 10 percent owner
 Warrants (Right to buy) 18,750 N/A N/A
Purchase
INTERWEST PARTNERS X LP 10 percent owner
 Common Stock 25,000 N/A N/A
Purchase
KAMDAR KIM P. director
 Common Stock 54,945 N/A N/A
Purchase
DOMAIN PARTERS VII L P 10 percent owner
 Common Stock 1,648,359 N/A N/A
Purchase
INTERWEST PARTNERS X LP 10 percent owner
 Common Stock 1,098,901 N/A N/A
Purchase
DRAKE NEIL officer: VP Research and Develo..
 Common Stock 5,000 N/A N/A
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 5,300 N/A N/A
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 19,288 $4.05 $78,097
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 19,288 N/A N/A
Option
DRAKE NEIL officer: VP Research and Develo..
 Employee Stock Option (right to buy) 8,180 N/A N/A
Option
DRAKE NEIL officer: VP Research and Develo..
 Common Stock 13,926 N/A N/A
Option
VANDENBERG AMY officer: Chief Clinical & Reg O..
 Common Stock 6,650 $1.02 $6,763
Option
VANDENBERG AMY officer: Chief Clinical & Reg O..
 Employee Stock Option (right to buy) 4,022 N/A N/A
Option
VANDENBERG AMY officer: Chief Clinical & Reg O..
 Common Stock 6,650 N/A N/A
Purchase
NORWOOD MATTHEW officer: VP of Sales
 Common Stock 1,000 N/A N/A
Purchase
KAMDAR KIM P. director
 Common Stock 13,400 N/A N/A

Showing 1 to 46 of 46 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: